HEATHER SMART: Open Payments
NPI 1285398578 · TARZANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,022 in 41 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $290 · 2025 $1,022
Food & beverage: $1,022
| Company | Payments | Amount |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 7 | $136 |
| ABBVIE INC. | 5 | $105 |
| Endo USA, Inc. | 4 | $104 |
| Janssen Biotech, Inc. | 3 | $102 |
| Dendreon Pharmaceuticals LLC | 3 | $97 |
| Antares Pharma, Inc. | 3 | $67 |
| Merck Sharp & Dohme LLC | 2 | $66 |
| Novartis Pharmaceuticals Corporation | 2 | $60 |
| Blue Earth Diagnostics | 2 | $55 |
| IMMUNITYBIO, INC. | 2 | $51 |
Products named: ADSTILADRIN, LUPRON DEPOT, ERLEADA, PROVENGE, XIAFLEX, XYOSTED, KEYTRUDA, PLUVICTO.
Industry payments across CA — which companies pay providers there.
